Conference on drug design and discovery technologies /

Conference on drug design and discovery technologies / editors: Manikanta Murahari [and 5 more]

Show other versions (1)

This publication is based on peer-reviewed manuscripts from the 2019 Conference on Drug Design & Discovery Technologies (CDDT) held at Ramaiah University of Applied Sciences, India. Providing a wide range of up to date topics on the latest advancements in drug design and discovery technologies,...

Full description

Saved in:
Bibliographic Details
Online Access: Full Text (via RSC)
Corporate Author: Conference on Drug Design & Discovery Technologies Karnataka, India
Other Authors: Murahari, Manikanta (Editor)
Format: Conference Proceeding eBook
Language:English
Published: [United Kingdom] : Royal Society of Chemistry, [2020]
Series:Special publication (Royal Society of Chemistry (Great Britain)) ; no. 355
Subjects:
Drug development > Congresses.
Pharmaceutical technology > Congresses.
Drug development.
Pharmaceutical technology.
Conference papers and proceedings.
Table of Contents:
  • Cover
  • Contents
  • Part 1: Structure Based Drug Design Approach
  • MOLECULAR DYNAMICS SIMULATIONS OF BACILLUS SUBTILIS EngA
  • FOR EXPLORING NUCLEOTIDE DEPENDENT CONFORMATIONS
  • ERRORS MADE IN AB INITIO+ HOMOLOGY-BASED PROTEIN STRUCTURE PREDICTION TOOLS ARISE DUE TO LACK OF CONSIDERATION OF IMPACT FORCES
  • PARADIGM SHIFT IN RESEARCH FOCUS: COMPUTATIONAL SOFTWARES IN CANCER BIOLOGY
  • VIRTUAL SCREENING OF BIO-ACTIVE COMPOUNDS AS ANINHIBITOR OF C-FLIP PROTEIN FOR CANCER TREATMENT.
  • FRAGMENT-BASED DESIGN OF NOVEL INHIBITORS OF HPV16 E6 ONCOPROTEIN: MOLECULAR DOCKING, MOLECULAR DYNAMICS SIMULATION AND ADME ANALYSIS
  • DESIGN AND SYNTHESIS OF NOVEL POLY ADP-RIBOSE POLYMERASE 1 (PARP1) INHIBITORS FOR THE TREATMENTOF SOLID TUMORS
  • IN SILICO EVALUATION OF THE ROLE OF PHYTOCHEMICALS IN ALZHEIMER'S DISEASE THROUGH WNT SIGNALINGMODULATION
  • IDENTIFICATION OF POTENTIAL VEGFR2 INHIBITORS EMPLOYING E-PHARMACOPHORE MODEL, VIRTUALSCREENING, MOLECULAR DYNAMIC SIMULATION ANDADME ANALYSIS.
  • DEVELOPMENT OF NEW NEPRILYSIN INHIBITOR AS AMODULATOR OF CHRONIC KIDNEY AND HEART DISEASE USING DRUG REPURPOSING APPROACH
  • ANTICANCER POTENTIAL OF PHYTOCONSTITUENTS MODULATING NA/K ATPASE PUMP
  • A NOVEL REPURPOSING STRATEGY
  • IN SILICO HIT IDENTIFICATION, DRUG REPURPOSING, PHARMACOKINETIC AND TOXICITY PREDICTION OF C-MET KINASE INHIBITORS FOR CANCER THERAPY
  • DESIGN POTENT TELOMERASE INHIBITORS USING STRUCTURE BASED APPROACHES.
  • MOLECULAR DOCKING BASED SCREENING OF "NITROGEN CONTAINING BISPHOSPHONATE CONJUGATE WITH HYDROXYAPATITE" ACTIVE CONSTITUENTS TOWARDS MEVALONATE PATHWAY IN FINDING POTENT INHIBITORS FOR ANTI-OSTEOPOROTIC ACTIVITY
  • ZANAPEZIL, A POTENTIAL REPURPOSABLE DRUG AGAINST HUNTINGTON DISEASE: AN IN SILICO FORECAST
  • DRUG REPURPOSING FOR HEPATOCELLULAR CARCINOMA VIA VIRTUAL SCREENING INTEGRATED WITH BIOINFORMATICS ANALYSIS
  • AN IN SILICO TARGET SPECIFIC DRUG REPURPOSING APPROACH FOR MULTIPLE SCLEROSIS
  • Part 2: Structure Based Drug Design and Biological Evaluation.
  • DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF 3-PHENYLISOXAZOLO[5,4-D]PYRIMI DINE DERIVATIVES ASANTICANCER AGENTS
  • QSAR AND DOCKING STUDIES ON TRIAZOLE BENZENESULFONAMIDES WITH HUMAN CARBONIC ANHYDRASE IXINHIBITORY ACTIVITY
  • DESIGN AND SYNTHESIS OF SOME NOVEL ERLOTINIBDERIVATIVES AS POTENTIAL EGFR KINASE INHIBITORS
  • DESIGN, SYNTHESIS AND CHARACTERIZATION OF NOVEL SERIES OF 1,3-THIAZOLE CONTAINING HETEROCYCLES AS INHIBITORS OF DHFR FOR USE AS ANTICANCER AGENTS
  • IN SILICO AND IN VITRO STUDIES OF BENZOHYDRAZIDE ANALOGUES AS POTENT ANDROGEN RECEPTOR ANTAGONIST.

Similar Items